These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 15748992)
1. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Parassol N; Freitas M; Thoreux K; Dalmasso G; Bourdet-Sicard R; Rampal P Res Microbiol; 2005 Mar; 156(2):256-62. PubMed ID: 15748992 [TBL] [Abstract][Full Text] [Related]
2. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Ingrassia I; Leplingard A; Darfeuille-Michaud A Appl Environ Microbiol; 2005 Jun; 71(6):2880-7. PubMed ID: 15932981 [TBL] [Abstract][Full Text] [Related]
3. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460. Liu ZH; Shen TY; Zhang P; Ma YL; Moyer MP; Qin HL World J Gastroenterol; 2010 Dec; 16(45):5759-65. PubMed ID: 21128328 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Martins FS; Silva AA; Vieira AT; Barbosa FH; Arantes RM; Teixeira MM; Nicoli JR Arch Microbiol; 2009 Aug; 191(8):623-30. PubMed ID: 19526225 [TBL] [Abstract][Full Text] [Related]
5. Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Czerucka D; Dahan S; Mograbi B; Rossi B; Rampal P Infect Immun; 2001 Mar; 69(3):1298-305. PubMed ID: 11179291 [TBL] [Abstract][Full Text] [Related]
6. Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells. Eun CS; Kim YS; Han DS; Choi JH; Lee AR; Park YK APMIS; 2011 Jan; 119(1):49-56. PubMed ID: 21143526 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Zyrek AA; Cichon C; Helms S; Enders C; Sonnenborn U; Schmidt MA Cell Microbiol; 2007 Mar; 9(3):804-16. PubMed ID: 17087734 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-8, CXCL1, and MicroRNA miR-146a Responses to Probiotic Escherichia coli Nissle 1917 and Enteropathogenic E. coli in Human Intestinal Epithelial T84 and Monocytic THP-1 Cells after Apical or Basolateral Infection. Sabharwal H; Cichon C; Ölschläger TA; Sonnenborn U; Schmidt MA Infect Immun; 2016 Sep; 84(9):2482-92. PubMed ID: 27297392 [TBL] [Abstract][Full Text] [Related]
9. Wang Y; Yan X; Zhang W; Liu Y; Han D; Teng K; Ma Y J Microbiol Biotechnol; 2019 Jun; 29(6):863-876. PubMed ID: 31091863 [TBL] [Abstract][Full Text] [Related]
10. Effect of probiotics on enterocyte bacterial translocation in vitro. Mattar AF; Drongowski RA; Coran AG; Harmon CM Pediatr Surg Int; 2001 May; 17(4):265-8. PubMed ID: 11409159 [TBL] [Abstract][Full Text] [Related]
11. Synergy between Probiotic Lactobacillus casei and Milk to Maintain Barrier Integrity of Intestinal Epithelial Cells. Zhai Z; Torres-Fuentes C; Heeney DD; Marco ML J Agric Food Chem; 2019 Feb; 67(7):1955-1962. PubMed ID: 30629420 [TBL] [Abstract][Full Text] [Related]
12. Indigenous lactobacilli strains of food and human sources reverse enteropathogenic E. coli O26:H11-induced damage in intestinal epithelial cell lines: effect on redistribution of tight junction proteins. Jariwala R; Mandal H; Bagchi T Microbiology (Reading); 2017 Sep; 163(9):1263-1272. PubMed ID: 28771130 [TBL] [Abstract][Full Text] [Related]
13. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Philpott DJ; McKay DM; Sherman PM; Perdue MH Am J Physiol; 1996 Apr; 270(4 Pt 1):G634-45. PubMed ID: 8928793 [TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction. Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566 [TBL] [Abstract][Full Text] [Related]
15. [Influence of Lactobacillus casei on biofilm formation by enteroaggregative Escherichia coli strains isolated from irritable bowel syndrome (IBS)]. Andrzejewska B; Sobieszczańska BM Med Dosw Mikrobiol; 2013; 65(1):11-7. PubMed ID: 24180127 [TBL] [Abstract][Full Text] [Related]
16. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Forestier C; De Champs C; Vatoux C; Joly B Res Microbiol; 2001 Mar; 152(2):167-73. PubMed ID: 11316370 [TBL] [Abstract][Full Text] [Related]
17. Lactobacillus casei Exerts Anti-Proliferative Effects Accompanied by Apoptotic Cell Death and Up-Regulation of TRAIL in Colon Carcinoma Cells. Tiptiri-Kourpeti A; Spyridopoulou K; Santarmaki V; Aindelis G; Tompoulidou E; Lamprianidou EE; Saxami G; Ypsilantis P; Lampri ES; Simopoulos C; Kotsianidis I; Galanis A; Kourkoutas Y; Dimitrellou D; Chlichlia K PLoS One; 2016; 11(2):e0147960. PubMed ID: 26849051 [TBL] [Abstract][Full Text] [Related]